FERMION OY

Overview

FERMION OY is an active pharmaceutical ingredient (API) supplier with 32 active FDA Type II Drug Master Files, covering 6-MERCAPTOPURINE; ALPRAZOLAM; AZATHIOPRINE; BUSPIRONE HYDROCHLORIDE; CABOZANTINIB S-MALATE; CARBIDOPA.

API / Drug Master Files

FERMION OY holds 32 active (43 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• NINTEDANIB HYDROBROMIDE DIHYDRATEActive2025-06-17
• TREOSULFANActive2020-06-29
• CABOZANTINIB S-MALATEActive2020-02-25
• NITROFURANTOIN MACROCRYSTALActive2019-11-20
• NITROFURANTOIN MONOHYDRATEActive2019-10-15
• FORMOTEROL FUMARATEActive2019-07-12
• NINTEDANIB ESYLATEActive2019-01-02
• HYDROXYCHLOROQUINE SULPHATEActive2015-11-24
• CARBIDOPAActive2012-09-14
• OSPEMIFENEActive2011-11-30
• QUETIAPINE FUMARATE "ALTERNATIVE PROCESS"Active2011-10-26
• METHOTREXATE DISODIUMActive2010-01-29
• IRINOTECAN HYDROCHLORIDEActive2007-06-29
• QUETIAPINE FUMARATE ACTIVE PHARMACEUTICAL INGREDIENTActive2006-02-02
• 6-MERCAPTOPURINEActive2001-01-15

Showing 15 of 43 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to FERMION OY in our records. PharmaTek screens the full directory against live FDA enforcement data.